Glycopyrrolate as a substitute for atropine: a preliminary report.
D000293:Adolescent; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001285:Atropine / Q000009:adverse effects / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced / Q000517:prevention & control; D005260:Female; D006024:Glycopyrrolate / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008333:Mandelic Acids / Q000494:pharmacology*; D008875:Middle Aged; D009388:Neostigmine / Q000009:adverse effects; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D010276:Parasympatholytics / Q000494:pharmacology*; D011229:Preanesthetic Medication; D011674:Pulse / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013610:Tachycardia / Q000139:chemically induced / Q000517:prevention & control
D008333:Mandelic Acids; D003473:Neuromuscular Nondepolarizing Agents; D010276:Parasympatholytics; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D009388:Neostigmine; D001285:Atropine; D006024:Glycopyrrolate